Overall, patients with STAT1 GOF (c.Y289C) mutations showed lower mortality and lower probability of failure to thrive (approximately 13.3% and 15.4% for STAT1 GOF, respectively) (36). This evidence concerns the gene STAT1 and Failure to thrive.